THC Farmaceuticals, Inc.
CBDG
$0.013
-$0.0011-7.80%
OTC PK
| 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | |
|---|---|---|---|---|---|
| Revenue | 4.50K | 4.80K | 4.40K | 4.80K | 4.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.50K | 4.80K | 4.40K | 4.80K | 4.40K |
| Cost of Revenue | 4.50K | 4.50K | 2.50K | 2.70K | 2.70K |
| Gross Profit | 0.00 | 300.00 | 1.90K | 2.10K | 1.70K |
| SG&A Expenses | 35.20K | 19.60K | 10.30K | 8.70K | 4.00K |
| Depreciation & Amortization | 200.00 | 300.00 | 200.00 | 200.00 | 200.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.90K | 24.40K | 12.90K | 11.50K | 6.90K |
| Operating Income | -35.40K | -19.50K | -8.50K | -6.80K | -2.50K |
| Income Before Tax | -35.70K | -19.80K | -8.50K | -8.60K | -4.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.70K | -19.80K | -8.50K | -8.60K | -4.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.70K | -19.80K | -8.50K | -8.60K | -4.30K |
| EBIT | -35.40K | -19.50K | -8.50K | -6.80K | -2.50K |
| EBITDA | -35.20K | -19.40K | -8.40K | -6.60K | -2.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 15.00M | 14.97M | 11.97M | 8.97M | 8.97M |
| Average Diluted Shares Outstanding | 15.00M | 14.97M | 11.97M | 8.97M | 8.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |